Profil
Eugene de Juan was the founder of Transcend Medical, Inc. (founded in 2005), ForSight VISION5, Inc. (founded in 2010) where the title held was Board Observer, Spiral Therapeutics, Inc. (founded in 2016) where the title held was Executive Chairman, and ForSight Labs LLC (founded in 2005) where the title held was Vice Chairman in 2010.
Dr. de Juan is also the founder of NeoVista, Inc.,InnoRx, Inc...
Dr. de Juan is Chief Executive Officer at ForSight VISION6, Inc., Principal at The University of California, San Francisco, and Advisor at Vensana Capital Management LLC.
Former positions include Chief Executive Officer at Doheny Eye Institute, Director at ForSight VISION4, Inc., Director at Neurotech Pharmaceuticals, Inc. (United States), Director at Refractec, Inc., Director-Vitreoretinal Service at Wilmer Eye Institute, and Director at Nexis Vision, Inc. Education includes a doctorate from the University of South Alabama.
Postes actifs de Eugene de Juan
| Sociétés | Poste | Début |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Spiral Therapeutics, Inc.
Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage company focuses on delivering therapies for inner ear disorder | Fondateur | 01/01/2016 |
ForSight VISION6, Inc.
ForSight VISION6, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Directeur Général | - |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million. | Consultant / Advisor | - |
Anciens postes connus de Eugene de Juan
| Sociétés | Poste | Fin |
|---|---|---|
Refractec, Inc.
Refractec, Inc. Medical SpecialtiesHealth Technology Develops and markets radio frequency devices | Directeur/Membre du Conseil | 10/08/2012 |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Directeur/Membre du Conseil | - |
Transcend Medical, Inc.
Transcend Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Fondateur | - |
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops ocular drug delivery technologies and device solutions for ophthalmic diseases | Fondateur | - |
ForSight VISION4, Inc.
ForSight VISION4, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drug delivery therapies for treatment of retinal diseases | Directeur/Membre du Conseil | - |
Formation de Eugene de Juan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
NeoVista, Inc.
NeoVista, Inc. Medical SpecialtiesHealth Technology Develops a device-based therapy for age-related macular degeneration | Health Technology |
Transcend Medical, Inc.
Transcend Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
ForSight VISION4, Inc.
ForSight VISION4, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drug delivery therapies for treatment of retinal diseases | Health Technology |
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops ocular drug delivery technologies and device solutions for ophthalmic diseases | Electronic Technology |
ForSight VISION6, Inc.
ForSight VISION6, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
InnoRx, Inc.
InnoRx, Inc. Electronic Equipment/InstrumentsElectronic Technology Designs medical devices | Electronic Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Alabama
University of South Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Refractec, Inc.
Refractec, Inc. Medical SpecialtiesHealth Technology Develops and markets radio frequency devices | Health Technology |
ForSight Labs LLC
ForSight Labs LLC Medical SpecialtiesHealth Technology Develops an ophthalmic technology designed to improve the sight, care and life of visually impaired patients | Health Technology |
Doheny Eye Institute
Doheny Eye Institute Miscellaneous Commercial ServicesCommercial Services Provides eye care related research and education programs | Commercial Services |
Wilmer Eye Institute | |
Nexis Vision, Inc.
Nexis Vision, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic solutions | Health Technology |
Spiral Therapeutics, Inc.
Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage company focuses on delivering therapies for inner ear disorder | Commercial Services |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million. | Finance |
















